PUBLIC CONTRACT · 2021
Q1/0118/2021 - Medicamentos antirretrovíricos VIH
- Contract value
- €13.14
- Signed on
- 14 January 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7391627PUBLISHED SUBJECT
Q1/0118/2021 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
Parties involved
- Place of performance
- Portugal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Unilfarma, Lda. · Tax ID 500293023
- Bidder
- Viv-Healthcare · Tax ID 509117961
- Bidder
- Generis, Lda. · Tax ID 508107997
- Bidder
- Mylan, Lda. · Tax ID 502248793
- Bidder
- Accord · Tax ID 508622263
Values and timeline
- Contract price
- €13.14
- Procedure base price
- €1,494,069.98
- Total effective price
- Not reported on Portal BASE
- Publication date
- 15 January 2021
- Award date
- 14 January 2021
- Signing date
- 14 January 2021
- Performance period
- 60 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Preço ou custo
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2019/40 - Medicamentos antirretrovíricos para o tratamento da infeção por VIH
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5024160
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.